Elliot C Nelson Selected Research

Monoacylglycerol Lipases

11/2015

Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elliot C Nelson Research Topics

Disease

8	Substance-Related Disorders (Drug Abuse) 12/2020 - 01/2010
7	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 06/2009
4	Borderline Personality Disorder (Personality Disorders, Borderline) 12/2020 - 08/2009
4	Alcoholism (Alcohol Abuse) 10/2018 - 01/2003
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 07/2014
3	Mental Disorders (Mental Disorder) 12/2020 - 06/2009
3	Marijuana Abuse (Cannabis Abuse) 04/2017 - 01/2003
3	Tobacco Use Disorder (Nicotine Dependence) 03/2016 - 08/2006
3	Wounds and Injuries (Trauma) 01/2016 - 03/2013
3	Heroin Dependence (Heroin Abuse) 01/2014 - 08/2011
2	Genetic Risk Score 01/2020 - 01/2016
2	Anxiety Disorders (Anxiety Disorder) 09/2009 - 08/2009
1	Pruritus (Itching) 01/2022
1	Migraine Disorders (Migraine) 01/2021
1	Back Pain (Backache) 01/2020
1	Parkinson Disease (Parkinson's Disease) 10/2019
1	Melanoma (Melanoma, Malignant) 11/2018
1	Alcohol-Related Disorders 04/2017
1	Conduct Disorder (Conduct Disorders) 01/2017
1	Cocaine-Related Disorders (Cocaine Addiction) 03/2016
1	Hepatitis C 04/2014
1	Anhedonia 07/2012
1	Self Mutilation 02/2010
1	Social Phobia 01/2010
1	Opiate Overdose 09/2009

Drug/Important Bio-Agent (IBA)

13	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2003
7	Heroin (Diamorphine)IBA 01/2022 - 01/2011
5	Illicit Drugs (Recreational Drugs)IBA 03/2013 - 08/2006
4	Nicotine FDA Link 04/2017 - 10/2006
3	Hypnotics and Sedatives (Sedatives)IBA 01/2010 - 01/2003
2	Cocaine (Cocaine HCl)IBA 01/2016 - 01/2003
2	EndocannabinoidsIBA 11/2015 - 07/2012
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2021
1	NRH - quinone oxidoreductase2IBA 01/2021
1	3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 10/2019
1	telomerase RNA (bTR)IBA 11/2018
1	A-factor (Streptomyces)IBA 01/2016
1	CannabinoidsIBA 11/2015
1	Monoacylglycerol LipasesIBA 11/2015
1	EnzymesIBA 11/2015
1	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 11/2015
1	mu Opioid Receptors (mu Opioid Receptor)IBA 10/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 07/2014
1	Opioid Receptors (Opioid Receptor)IBA 01/2014
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2012
1	Corticotropin-Releasing HormoneIBA 12/2011
1	N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA 12/2011
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 12/2011
1	4-aminospiroperidolIBA 01/2011
1	Hallucinogens (Psychedelics)IBA 01/2003

Therapy/Procedure

2	Opiate Substitution Treatment 04/2014 - 03/2013
1	Precision Medicine 12/2020
1	Treatment Delay 10/2018
1	Secondary Prevention 06/2009